Doctors are seeing such cases around the world: About a third of COVID-19 patients go on to develop “long-haul” neurological or psychiatric conditions months after being infected, new research shows. The findings suggest a link between COVID-19 and a higher risk for later mental health and neurological disorders, researchers report. The new analysis of data… read on > read on >
It probably won’t show up on any real estate listing, but making your home in a place with many different kinds of birds and plants may be good for you. That’s the upshot of a German study that showed people who live in areas with greater biodiversity have better mental health than those in areas… read on > read on >
You might think regret has an upside — to help you avoid repeating a mistake — but new research shows it’s just not so, especially when it comes to casual sex. Researchers from the Norwegian University of Science and Technology asked volunteers to fill out a questionnaire about sexual regret — twice, about 4½ months… read on > read on >
Americans’ trust in the Centers for Disease Control and Prevention (CDC) has declined during the COVID-19 pandemic, an opinion poll finds. Researchers polled more than 2,000 Americans in May 2020 and questioned most again five months later. Respondents were asked to rate their trust of the CDC, the U.S. Postal Service (USPS) and the Federal… read on > read on >
U.S. children commonly wait hours in the emergency room for help with a mental health crisis — a problem that has worsened over time, a new study finds. Researchers found that between 2005 and 2015, prolonged ER stays became ever more common for children and teenagers in need of mental health help. By 2015, nearly… read on > read on >
There’s good news for the millions of Americans who’ve already received a dose or two of Moderna’s COVID-19 vaccine: New research shows the vaccine should protect against illness for at least six months. The new study tracked 33 participants in the trials that led to the vaccine’s approval. Six months after having received their second… read on > read on >
The first new drug developed in over a decade for children with attention deficit hyperactivity disorder (ADHD) has been approved by the U.S. Food and Drug Administration. Qelbree, also known as viloxazine, comes in a capsule that is taken daily, and is not a stimulant. This makes it harder to abuse than older ADHD drugs,… read on > read on >
When the pandemic first hit last spring, screening mammograms fell by the wayside as COVID-19 became the most pressing medical concern in the country, but U.S. testing rates rebounded by mid-summer, a new study shows. But even though things have returned to normal, it still hasn’t been enough to make up for those three months… read on > read on >
TUESDAY, April 6, 2021 (American Heart Association News) — A pandemic, protests and politics have highlighted the nation’s long-standing, deep-seated racial issues and how they affect the health of millions of Americans. People who’ve never confronted racism before are asking, “How can I show I’m an ally?” For the uninitiated, being a partner in the… read on > read on >
TUESDAY, April 6, 2021 (American Heart Association News) — James “Pete” Watt walked into a physical therapy appointment in April 2018 feeling unusually lightheaded and anxious. “I just felt off,” he said. The therapist took his blood pressure reading. It was dangerously high – 200/100. “You’re not going anywhere until someone comes to get you,”… read on > read on >
